Indeed, eosinophils play controversial roles in modulating tumor initiation and progression, for that they are both the source of anti-tumorigenic factors including TNF-a, granzyme, cationic proteins, and IL-18, and protumorigenic molecules such as pro-angiogenic factors, depending on the different immune milieu (35). The gene discussed is IL18; the disease is neoplasm.